Why is Proprio important?
The Proprio Paradigm technology has the potential to revolutionize orthopedic and spine surgery in a number of ways. First, it can eliminate the need for intraoperative scans, which reduces radiation exposure to the patient and surgical staff. This can save up to 30 minutes per procedure, increasing the availability of care to patients.
Second, the Paradigm system delivers a high degree of accuracy by quickly registering imaging data to the anatomy within surgical workflows. This can help surgeons to avoid errors and complications, and it can also improve patient outcomes.
Third, the Paradigm system is capable of collecting a tremendous amount of surgical data that can be utilized for the development of many applications beyond status quo approaches to surgery. For example, this data could be used to develop new surgical techniques, to improve training for surgeons, or to track patient outcomes over time.
Overall, the Proprio Paradigm technology has the potential to make orthopedic and spine surgery safer, more efficient, and more effective. This could lead to significant improvements in patient care and outcomes.
Here are some specific examples of how the Proprio Paradigm technology could change surgery in the future:
- The technology could be used to improve the accuracy of spine surgery. This could lead to a reduction in complications, such as nerve damage.
- The technology could be used to develop new surgical techniques for spine surgery. This could lead to less invasive procedures with faster recovery times.
- The technology could be used to track patient outcomes after spine surgery. This could help surgeons to identify and address problems early on.
The Proprio Paradigm technology is still in its early stages of development, but it has the potential to revolutionize orthopedic and spine surgery. As the technology continues to develop, we can expect to see even more ways in which it can improve patient care.
Proprio announced today that it secured $43 million in a Series B funding round that included new and existing investors.
The capital infusion aids the company’s commercialization efforts for its AI-driven surgical navigation platform in the U.S. and overseas.
Seattle-based Proprio designed its Paradigm surgical navigation platform to replace traditional surgical navigation technologies. Using an advanced approach, it avoids the pitfalls that pull attention away from the patient and disrupt workflows. FDA cleared Paradigm in April.
The system uses light field technology and AI to generate a real-time, 3D visualization of surgery. It provides surgeons with the Proprio Volumetric Intelligence, which combines medical images with live data from Paradigm’s sensor suite.
Proprio says its Paradigm system eliminates the need for intraoperative scans, reducing radiation exposure. This saves up to 30 minutes per procedure, too. By quickly registering imaging data to the anatomy within surgical workflows, the system delivers accuracy and enables surgeons to maintain focus.
The Paradigm system can collect “a tremendous amount of surgical data,” according to a news release. This can hep develop many applications that go beyond the status quo approaches to surgery.
“We are just beginning to reveal the potential applications of Proprio’s technology and data,” said Gabriel Jones, CEO and co-founder of Proprio. “This investment arrives at a pivotal moment, as we perform our first-in-human cases and bring Paradigm to patients around the world. Together, these milestones are a testament to the unparalleled capabilities of the Proprio Paradigm and its potential to revolutionize surgery.”